LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

Search

Progyny Inc

Geschlossen

BrancheGesundheitswesen

21.19 2.62

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

20.61

Max

21.46

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.2M

14M

Verkäufe

-20M

313M

KGV

Branchendurchschnitt

33.371

110.024

EPS

0.45

Gewinnspanne

4.425

Angestellte

675

EBITDA

-3.1M

25M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+41.33% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

26. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

199M

1.8B

Vorheriger Eröffnungskurs

18.57

Vorheriger Schlusskurs

21.19

Nachrichtenstimmung

By Acuity

17%

83%

19 / 351 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Progyny Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. Feb. 2026, 22:53 UTC

Akquisitionen, Fusionen, Übernahmen

Keurig Dr Pepper Raises Additional $1.5 Billion in Deal to Split Company

23. Feb. 2026, 22:36 UTC

Ergebnisse

Kratos Defense & Security Solutions 4Q Profit Rises; Sees Federal Shutdown Denting 1Q -- Update

23. Feb. 2026, 22:32 UTC

Ergebnisse

Woodside Energy Fiscal Year Net Profit Falls 24%

23. Feb. 2026, 23:58 UTC

Market Talk
Ergebnisse

Plenty of Questions for Woodside Despite Well-Guided Result -- Market Talk

23. Feb. 2026, 23:58 UTC

Market Talk
Ergebnisse

Global Energy Roundup: Market Talk

23. Feb. 2026, 23:47 UTC

Market Talk

Scentre's Share Price Slips as Earnings Guidance Underwhelms -- Market Talk

23. Feb. 2026, 23:43 UTC

Market Talk

Gold Edges Higher Amid Ongoing Tariff Risks -- Market Talk

23. Feb. 2026, 23:41 UTC

Akquisitionen, Fusionen, Übernahmen

Crescent Capital Partners Owns 53% of ClearView Wealth

23. Feb. 2026, 23:40 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Says Crescent Capital Partners Intends to Support Deal

23. Feb. 2026, 23:40 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Says Directors Unanimously Recommend Shareholders Vote in Favor of Deal

23. Feb. 2026, 23:40 UTC

Market Talk

Nikkei May Rise as Investors Assess Tariff Developments -- Market Talk

23. Feb. 2026, 23:40 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Says Zurich Insurance Offering A$0.65/Share in Cash

23. Feb. 2026, 23:39 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Agrees to Takeover by Zurich Insurance Group Unit

23. Feb. 2026, 23:31 UTC

Ergebnisse

United Overseas Bank 2025 Total Dividend S$1.56/Shr >U11.SG

23. Feb. 2026, 23:31 UTC

Ergebnisse

United Overseas Bank Proposes Final Dividend of S$0.71/Shr Vs. S$0.92/Shr >U11.SG

23. Feb. 2026, 23:28 UTC

Ergebnisse

United Overseas Bank 4Q Net Interest Income S$2.35B Vs. S$2.45B >U11.SG

23. Feb. 2026, 23:28 UTC

Ergebnisse

United Overseas Bank 4Q Oper Pft S$1.76B Vs. Pft S$1.88B >U11.SG

23. Feb. 2026, 23:28 UTC

Ergebnisse

United Overseas Bank 4Q Total Income S$3.29B Vs. S$3.46B >U11.SG

23. Feb. 2026, 23:27 UTC

Ergebnisse

United Overseas Bank 4Q Net S$1.41B Vs. Net S$1.52B >U11.SG

23. Feb. 2026, 23:24 UTC

Market Talk

Major Miners On Whole Delivered Positive Earnings Season -- Market Talk

23. Feb. 2026, 22:38 UTC

Akquisitionen, Fusionen, Übernahmen

Keurig Dr Pepper Raises Additional $1.5B in Deal to Split Company

23. Feb. 2026, 22:31 UTC

Ergebnisse

Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors. -- Barrons.com

23. Feb. 2026, 22:24 UTC

Ergebnisse

Viva Energy Energy & Infrastructure Ebitda A$93 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy FY Commercial & Industrial Ebitda A$460.5 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy FY Convenience & Mobility Ebitda A$197.4 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy FY Underlying Ebitda A$700.9 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy Final Dividend 3.94 Australian Cents/Security

23. Feb. 2026, 22:21 UTC

Ergebnisse

Viva Energy FY Revenue A$28.53 Billion, Down 1.1%

23. Feb. 2026, 22:21 UTC

Ergebnisse

Viva Energy FY Replacement-Cost Net Profit A$183.6 Million, Down 28%

23. Feb. 2026, 22:20 UTC

Ergebnisse

Viva Energy FY Historical-Cost Net Loss A$421.1 Million

Peer-Vergleich

Kursveränderung

Progyny Inc Prognose

Kursziel

By TipRanks

41.33% Vorteil

12-Monats-Prognose

Durchschnitt 29.65 USD  41.33%

Hoch 35 USD

Tief 21.92 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Progyny Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

7 ratings

6

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

22.91 / 23.375Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

19 / 351 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
help-icon Live chat